Deep science. Real-world applications.
About HYH Biotechnology
HYH Biotechnology is a Brazilian deep tech company specializing in turning complex biological challenges into technological assets.
We integrate bioinformatics, molecular engineering, and experimental validation to develop bioactive peptides, RNA interference technologies, and diagnostic solutions tailored to industry needs.
PRISMA®: From biological challenge to technological asset
PROPRIETARY TECHNOLOGY PLATFORM
The PRISMA® Platform integrates computational intelligence, molecular engineering, and experimental validation to identify, design, and develop bioactive molecules for industrial applications.
Each project starts with a specific challenge and follows a structured process of discovery, selection, and validation, reducing development time and technological risks.
Molecular precision across markets
APPLICATION AREAS
The PRISMA® Platform delivers technological solutions addressing strategic challenges across four key areas.
From industrial challenge to technological asset
HOW WE WORK
Our Research as a Service (RaaS) model brings together science, strategy, and technology development in a structured process.
TECHNOLOGIES
Diverse expertise. One integrated platform.
HYH Biotechnology brings together scientific expertise across multiple disciplines to develop solutions that address real industry challenges:
→ Bioactive peptides
→ RNA interference
→ Bioinformatics and molecular modeling
→ Diagnostic technologies
→ Experimental validation
This integration connects discovery, engineering, and application in a single development process.
Technologies designed to go beyond discovery
EVIDENCE-DRIVEN SCIENCE
From molecular modeling to experimental validation, every decision is guided by scientific evidence.
HYH IN THE MIDIA
Our science featured in leading media outlets
Explore the news stories, interviews, and recognition highlighting the work of HYH Biotechnology.